Incidence of Respiratory Syncytial Virus in Community-Dwelling Adults Aged 18–64 Years Over 2 Seasons, 2022–2024, in a North American Community
Our observations suggest that RSV-ARI incidence and seasonal pattern are shifting to prepandemic RSV epidemiology.
Authors
- Matthew J. Binnicker (ORCID: https://orcid.org/0000-0003-2537-7165)
- Kathy Ihrke
- Joseph D. Yao (ORCID: https://orcid.org/0000-0002-5988-8927)
- Chung‐Il Wi (ORCID: https://orcid.org/0000-0001-8938-2997)
- Young J. Juhn (ORCID: https://orcid.org/0000-0003-2112-4240)
- Traci L. Natoli
- Robert J. Pignolo (ORCID: https://orcid.org/0000-0002-8533-9438)
- Brandon H. Hidaka (ORCID: https://orcid.org/0000-0002-2378-3621)
- Mohamed Oujaa
- Paul Y. Takahashi (ORCID: https://orcid.org/0000-0002-1891-309X)
- Randy Foss (ORCID: https://orcid.org/0000-0003-3898-7317)
- Katherine S. King (ORCID: https://orcid.org/0000-0002-8043-9640)
- Lisa Speiser (ORCID: https://orcid.org/0000-0002-7017-3607)
- Wendelyn Bosch (ORCID: https://orcid.org/0000-0003-3021-2752)
- Matthew J. Spiten
- Pouya Saeedi
- Jean‐Yves Pirçon
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- GlaxoSmithKline (Belgium) (BE)
- Mayo Clinic Health System (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/ofid/ofae597
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- GlaxoSmithKline
- GlaxoSmithKline foundation